CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • Á¶°æ±â
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø ½Å°æ¿Ü°ú
  • Àü¹®ºÐ¾ß : ³úÁ¾¾ç, ³úÇ÷°üÁúȯ
  • Á÷ À§: ±³¼ö
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö: http://blog.naver.com/sandori44
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
288 (±¹³»)SCI The Relationship between Parkinson¡¯s Disease and Acute Myocardial Infarction in Korea : A Nationwide Longitudinal Cohort Study
287 (±¹¿Ü)SCI Extended endoscopic transorbital approach with superior-lateral orbital rim osteotomy: cadaveric feasibility study and clinical implications (SevEN-007)
286 (±¹¿Ü)SCIE Big Data Analysis of the Risk of Intracranial Hemorrhage in Korean Populations Taking Low-Dose Aspirin
285 (±¹¿Ü)SCI A Robustly Supported Extracellular Matrix Improves the Intravascular Delivery Efficacy of Endothelial Progenitor Cells
284 (±¹³»)±âŸ ³ú¼Õ»ó ÁßȯÀÚÀÇ ¿¡³ÊÁö ¿ä±¸·® ºñ±³: °£Á¢¿­·®ÃøÁ¤±â vs ¿¹Ãø¹æÁ¤½Ä¹èÀº
283 (±¹³»)KCI Optimal microcatheter shaping method customized for a patient-specific vessel using a three-dimensional printer
282 (±¹¿Ü)SCIE "miR-542-3p Contributes to the HK2-Mediated High Glycolytic Phenotype in Human Glioma Cells"
281 (±¹¿Ü)SCIE "Autologous adoptive immune-cell therapy elicited a durable response with enhanced immune reaction signatures in patients with recurrent glioblastoma: An open label, phase I/IIa trial"
280 (±¹¿Ü)SCIE "Maximal surgical resection and adjuvant surgical technique to prolong the survival of adult patients with thalamic glioblastoma"
279 (±¹¿Ü)SCI Safety and efficacy of Wharton's jelly?derived mesenchymal stem cells with teriparatide for osteoporotic vertebral fractures: A phase I/IIa study
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 6 7 8 9 10 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729